Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
We Are Available 24/ 7. Call Now.
RBC Capital Upgrades Elevance Health, Inc. (ELV)
On March 28, 2023, RBC Capital upgraded their outlook for Elevance Health, Inc. (NYSE:ELV) from Sector Perform to Outperform. Analyst Price Forecast Suggests 29.15% Upside
RBC Capital Initiates Coverage of Legend Biotech (LEGN) with Outperform Recommendation
On March 24, 2023, RBC Capital initiated coverage of Legend Biotech with a Outperform recommendation. Analyst Price Forecast Suggests 57.86% Upside As of March 25,